The overall goal of this proposal is to determine how the expression of two genetic isoforms of creatine kinase (MCK and BCK) is regulated in mammalian heart cells. The specific objectives are: (1) to identify cis-acting DNA elements within the mouse MCK gene which are required for tissue- and/or cardiac cell type-specific expression of MCK; (2) to identify cis-acting DNA elements within the MCK gene which are required for various physiological modulations of its expression; (3) to clone the 5'-flanking and first intron portion of the mouse BCK gene, and to identity similar cell type and physiological regulatory elements within it; (4) to identify and begin purification of the trans-acting factors that bind to these DNA regions or that selectively stimulate or repress transcription from the M- and BCK promoter regions; and (5) to derive permanent cell lines which are representative of the various cardiac muscle cell types (atrial, ventricular, and conducting), as well as cardiac progenitor cells. Basic knowledge derived from these studies may be particularly informative with respect to the general problem of tissue-specific gene regulation during development. Our approach will permit direct comparisons between how the expression of two evolutionarily-related genes is regulated within a set of developmentally-related cell types in the cardiac and skeletal muscle cell lineages. In addition, since the creatine kinases play a critical role in the high-energy phosphate shuttle of cardiac muscle cells, and since CK levels appear to change in response to cardiac hypertrophy, these studies should provide information which is relevant to general problems of heart disease. Finally, the availability of permanent cell lines representing different cardiac muscle cell types would be of great value to virtually all studies of heart cell function. Major methodologies include: gene cloning, modification, transfection, DNAase foot-printing, gel retardation, in vitro transcription assays, clonal cell culture, and spontaneous, oncogene-, and viral-induced transformation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL039070-02
Application #
3355617
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1987-08-01
Project End
1990-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Buskin, J N; Gregory, D L; La-Framboise, W A et al. (1996) Harvest protocol to reduce variability of soluble enzyme yield from cultured cells. Biotechniques 20:92-4, 96-8, 100
Donoviel, D B; Shield, M A; Buskin, J N et al. (1996) Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol Cell Biol 16:1649-58
Shield, M A; Haugen, H S; Clegg, C H et al. (1996) E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice. Mol Cell Biol 16:5058-68
Apone, S; Hauschka, S D (1995) Muscle gene E-box control elements. Evidence for quantitatively different transcriptional activities and the binding of distinct regulatory factors. J Biol Chem 270:21420-7
Morton, M E; Brumwell, C; Gartside, C L et al. (1994) Characterization of muscarinic acetylcholine receptors expressed by an atrial cell line derived from a transgenic mouse tumor. Circ Res 74:752-6
Sculptoreanu, A; Morton, M; Gartside, C L et al. (1992) Tetrodotoxin-insensitive sodium channels in a cardiac cell line from a transgenic mouse. Am J Physiol 262:C724-30
Johnson, J E; Wold, B J; Hauschka, S D (1989) Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol 9:3393-9
Behringer, R R; Peschon, J J; Messing, A et al. (1988) Heart and bone tumors in transgenic mice. Proc Natl Acad Sci U S A 85:2648-52